2008
Cure Alzheimer’s Fund is part of a funding consortium supporting collaborative biomarker investigation of the elevation of tau and decreased concentrations of Amyloid beta 42 in the Central Spinal Fluid as evidence of the presence of the Alzheimer’s disease pathology.
Biomarkers/Diagnostics/Studies of Risk & Resilience, Foundational
John Q. Trojanowski, M.D., Ph.D.
Leslie M. Shaw, Ph.D.
Andrew Yoo, | 2021
Brain Donor Project, | 2021
Christina Lill, Lars Bertram, | 2020
Bradley Hyman, | 2020
Paola Bovolenta, Pilar Esteve, | 2020
Krista L. Moulder, | 2020
Shirley Wray,
Brad Racette, Alejandra Camacho-Soto, Susan Searles Nielsen, | 2019